Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.
about
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDSCurrent epidemiology of Pneumocystis pneumoniaImmunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions.Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in ChinaHIV: primary and secondary prophylaxis for opportunistic infections.Lost-to-care and engaged-in-care HIV patients in Leningrad Oblast, Russian Federation: barriers and facilitators to medical visit retention.Incidence and risk factors for AIDS-related mortality in HIV patients in China: a cross-sectional study.Assessing the performance of a computer-based policy model of HIV and AIDSLiving-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.Miliary tuberculosis coinfection with human immunodeficiency virus.Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections.AIDS-related cancer and severity of immunosuppression in persons with AIDS.Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United StatesFactors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM).Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens.CCR2 genotype and disease progression in a treated population of HIV type 1-infected women.Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational studyMortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand.Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infectionHealth Protective Behaviors among Young People Living with HIV/AIDSDiscontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized TherapyBimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoringNon-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunitiesAssociations and Trends in Cause-Specific Rates of Death Among Persons Reported with HIV Infection, 23 U.S. Jurisdictions, Through 2011.Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States.HIV protease inhibitors: recent clinical trials and recommendations on use.CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.In-hospital mortality rates and HIV: a medical ward review, Lilongwe, Malawi.The advent of successful organ transplantation in the Irish HIV positive cohort.Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer.
P2860
Q24685909-5EAE35E7-A992-485F-9365-24DD6F65E862Q28289603-F2DD5079-4D87-44AF-8684-AECB36B15647Q33321334-C824E3DB-2415-4EB8-BE80-233C040F5A9CQ33369974-48C8FE51-FC45-4E86-B6E4-384735B0C38EQ33585427-E713FBEB-5960-4357-9327-0C50FB82C58EQ33721818-3C16E9F5-666D-4F1F-91E6-AA2F614A054EQ33833865-BD36C123-3FE7-478F-AFEA-577FAA5A4820Q33850498-199600B3-1FA8-41D3-AA66-DAD0A3155476Q33864530-A9AB1A14-29D7-40DE-B103-F4B6B4E939A5Q34062712-7CCCFEE4-B808-4E9A-BB10-6AEC19D48842Q34115343-B68C44FE-6BF8-414C-8250-9B90AAA29E17Q34302103-89F1667F-C31E-4710-B82A-BB59ADFA4CDAQ34522835-B09FF801-0E33-4D3A-B16F-80E07D987DC5Q34613114-13F3E074-C3CD-4E26-87FA-E05BC7AE0C37Q34636933-C9B62430-150C-47A2-8580-170F679776A4Q34643410-F21001D6-4B12-4B36-8493-B3F47793A940Q35053172-5DBA99AC-5A1B-49AC-B8C3-2BB6AA804D27Q35080529-448C2298-E92E-4110-BBDC-209F8CE26540Q35187455-E6DE050A-32E7-46C0-B652-9023335531BDQ35232696-0D81EDAC-111A-4DA2-90E1-2015FAACED4CQ35452217-522CA322-CB3E-4644-B90C-0F5158538616Q35530073-A6BD593E-4F7B-4621-9DA1-DE03336DDCA4Q35605497-FB0EEA07-4008-4474-B7F7-B8E5C4E1FA8EQ35920633-4B57966D-CA66-4B64-ACC1-B1C39BA49B11Q35965602-B0FB782A-09A3-43FE-B26D-0A41665FEACAQ36088274-48E912B1-3A29-4EA6-B8D8-81A75EC71E42Q36240585-FE0D6987-03B1-434D-A989-58FB3B064841Q36456737-6998EBCC-65B3-45FA-8B9C-AD6ADB2F90F0Q36461601-EBB576D6-C36B-4B80-ADC7-0C6AF5054A42Q36503629-8D8F2875-D6EB-4AFE-B8F4-D1688D499B24Q36628396-357EE03D-C130-4F15-B122-547BA64FA611Q36933327-23510ABA-7BED-423A-9F83-B9251E0E4613Q37180845-10FB1479-3024-4B41-9C54-3800F3D7B88AQ37286865-83C3BC14-8DF7-42A5-95C2-2A0AAD5D90DEQ37388428-6C3FFFB0-B22D-4378-A44A-CB2759E76A4EQ37519715-D0C94926-3F16-4A7F-BF2E-8F46B77614E1Q37596720-9473B043-12E1-4039-B04D-DF1D35CEB319Q37906931-90182154-3503-4FA0-830D-BBE880B51A0BQ37919761-FB085F48-DE1A-49FE-B806-5D1017E28B66Q38403451-F9C116B1-5A42-485A-83E8-41A668F1BA1A
P2860
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effectiveness of potent antire ...... fore and after AIDS diagnosis.
@ast
Effectiveness of potent antire ...... fore and after AIDS diagnosis.
@en
type
label
Effectiveness of potent antire ...... fore and after AIDS diagnosis.
@ast
Effectiveness of potent antire ...... fore and after AIDS diagnosis.
@en
prefLabel
Effectiveness of potent antire ...... fore and after AIDS diagnosis.
@ast
Effectiveness of potent antire ...... fore and after AIDS diagnosis.
@en
P2093
P1433
P1476
Effectiveness of potent antire ...... fore and after AIDS diagnosis.
@en
P2093
P304
P356
10.1097/00002030-200102160-00008
P407
P577
2001-02-01T00:00:00Z